Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_assertion type Assertion NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_head.
- NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_assertion description "[BRAF mutations (V600E) were observed in 45.8% (11 of 24) of HPs, 60.9% (14 of 23) of SSAs, and 63.6% (7 of 11) of SSANs, and were equally found in both SSA and carcinoma/HGD areas of the individual SSANs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_provenance.
- NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_assertion evidence source_evidence_literature NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_provenance.
- NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_assertion SIO_000772 21263251 NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_provenance.
- NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_assertion wasDerivedFrom befree-20140225 NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_provenance.
- NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_assertion wasGeneratedBy ECO_0000203 NP454508.RAtKDT80HivqeyJNnX4w6FASV80Qf2f04tAUFDkhdlVXc130_provenance.